Generally, researchers restart the titration schedule with retatrutide regardless of their previous dose, though some experienced practitioners adjust based on their GLP-1 tolerance history
Tirzepatide vs Semaglutide: Dosage Comparison for Weight Loss Dr Titilayo Akinsola Oct 2, 2025 5 min read If youre considering medication-assisted weight loss, two of the most discussed options are semaglutide (GLP-1 agonist) and tirzepatide (GIP + GLP-1 dual agonist)
GLP-1 medications are not recommended for people with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2)
For individuals with obesity or who are overweight without Type 2 diabetes, data from the STEP 1, 3, 4, and 8 trials showed that semaglutide 2.4 mg was associated with average weight losses of 15% to 17% from baseline to week 68
long-term human safety data remain limited
Required fields are marked IMT (0customers review) Garki, Abuja (FCT), Nigeria Started from: Dec 15, 2022